Date Filed | Type | Description |
02/11/2022 |
SC 13G/A
| Champlain Investment Partners, LLC reports a 0% stake in Cantel Medical Corp. |
07/02/2021 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
06/29/2021 |
SC TO-I/A
| Form SC TO-I/A - Tender offer statement by Issuer: [Amend] |
06/14/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
06/10/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
06/08/2021 |
8-K
| Quarterly results |
06/03/2021 |
SC TO-I
| Form SC TO-I - Tender offer statement by Issuer: |
06/02/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/02/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/02/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/02/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/02/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
05/28/2021 |
10-Q
| Quarterly Report for the period ended April 30, 2021 |
05/28/2021 |
SD
| Form SD - Specialized disclosure report: |
05/19/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
05/19/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
05/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
05/03/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
04/29/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
04/29/2021 |
8-K
| Quarterly results |
04/27/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
04/27/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
04/21/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
04/21/2021 |
8-K
| Quarterly results |
04/12/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
04/01/2021 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
04/01/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
04/01/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
04/01/2021 |
8-K
| Quarterly results |
03/11/2021 |
GN
| SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Buyout Investigation |
03/10/2021 |
SC 13G/A
| ALGER ASSOCIATES INC reports a 0.6% stake in Cantel Medical Corp. |
03/10/2021 |
10-Q
| Quarterly Report for the period ended January 31, 2021 |
03/09/2021 |
8-K
| Quarterly results |
03/02/2021 |
GN
| SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Buyouts |
|